Nasdaq GlobeNewswire

Jessye Norman awarded The Twelfth Glenn Gould Prize

Del

TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- One of the great singers of her generation, renowned for her extraordinary voice and musical versatility, American opera singer and recitalist Jessye Norman has been chosen as The Twelfth Glenn Gould Prize Laureate.  Throughout her career, the sheer size, power and luster of her voice has shared equal acclaim with that of her thoughtful music-making, innovative programming of the classics, and fervent advocacy of contemporary music.  More than forty years after making her operatic debut, Jessye Norman continues to maintain a busy performance schedule, now concentrating on recitals and concerts.

"It is with the utmost humility and gratitude that I accept this magnificent honor, The Glenn Gould Prize. I was thrilled to have answered the telephone myself and to have heard this most wonderful news firsthand! My admiration for the artistic genius of Glenn Gould began very early on in my studies and was further supported in my having had Walter Homburger as the first presenter to invite me to perform in Canada.  His work with Glenn Gould is, of course, legendary," stated Jessye Norman. "It was he who made certain that I could experience on film the music of Bach played by a master of the keyboard and intellect of the highest order. Thank you, Walter. Thanks to The Glenn Gould Foundation. To have been chosen to receive this auspicious recognition is quite simply breath-taking!"

"We had a very thorough series of discussions that helped us to gradually narrow down an impressive list of nominees, always bearing in mind Glenn Gould's legacy and impact as a unique artist," said Viggo Mortensen, Chair of The Glenn Gould Prize Jury. "The day-long winnowing process became increasingly challenging as we got down to a handful of finalists, but we were united in our admiration for The Twelfth Glenn Gould Prize Laureate, the incomparable Jessye Norman."

"All of us at The Glenn Gould Foundation are beyond thrilled at the inspired selection made by this year's jury.  Jessye Norman is undoubtedly one of the great vocal artists of our time, or any time, but so much more. Her career has provided a positive role model for countless artists coming from disadvantaged circumstances as she did and overcoming the very real racial barrier that thwarted so many careers. Her triumph is an expression of the power of art to transcend all human boundaries," said Brian Levine, Executive Director of The Glenn Gould Foundation.

Jessye Norman made her operatic debut in 1969 at the Deutsche Oper Berlin and has since won acclaim for her performances in a wide range of leading roles with the world's premier opera companies, in solo recitals and in concerts with preeminent orchestras around the globe.  Her exceptional artistry has earned her the reputation as one of the most versatile concert and operatic singers of her time.  She has more than seventy-five recordings of her eclectic repertoire to her credit. She is well known for her mastery of the music of Richard Strauss, one of Glenn Gould's favourite composers.  Given the exceptional range of her voice, she has sung the repertoire of sopranos, mezzo-sopranos and altos throughout her career.  She has also begun to sing jazz, in concert and in multi-media collaborations, and she has performed an extensive repertoire of contemporary music.

Ms. Norman is the recipient of many international awards and honours including The Kennedy Center Honor, five Grammy awards including the Grammy Lifetime Achievement Award for Classical Music, The National Medal of Arts, and her many other prestigious distinctions include honourary doctorates at more than forty colleges, universities and conservatories around the world.

Known as a devoted mentor and generous supporter of young artists and emerging talent, Ms. Norman is also admired for her humanitarian contributions and attributes her citizenship and sensitivity to the examples of community service set by her parents.  She helped to establish The Jessye Norman School of the Arts in her hometown of Augusta, Georgia and is often called upon to speak to her passionate involvement and advocacy of arts education. Ms. Norman serves on the Boards of Directors for numerous organizations including The New York Public Library, Carnegie Hall, The Dance Theatre of Harlem, and The New York Botanical Gardens.  She is national spokesperson for The Partnership for the Homeless and a lifetime member of the Girl Scouts of America.

Jessye Norman was chosen from a distinguished list of international candidates across a broad spectrum of creative disciplines, nominated by members of the general public worldwide. Ms. Norman will receive a cash award of $100,000 (CAD) and The Glenn Gould Prize statue by Canadian artist Ruth Abernethy.

Ms. Norman will choose an outstanding young artist or ensemble to receive The City of Toronto Glenn Gould Protégé Prize of $15,000 (CAD), one who embodies the qualities of creative promise, innovation and career potential demonstrated by Gould in his youth.  The recipient of the Protégé Prize will be announced later this year. Both Ms. Norman and her protégé will receive their award at a gala ceremony and their work will be honoured through a series of public events presented within the next year.

The Twelfth Glenn Gould Prize Jury was chaired by Academy Award-nominated actor, painter, poet, and musician Viggo Mortensen (United States/Denmark); Academy and Grammy Award-winning director of film, opera and theatre, and accomplished screenwriter François Girard (Canada); singer and actress Ute Lemper (Germany); writer and former Chief Justice The Right Honourable Beverley McLachlin (Canada); painter and conservationist Naeemeh Naeemaei (Iran); acclaimed soprano Sondra Radvanovsky (Canada/United States); Academy Award-winning composer and conductor Howard Shore, OC (Canada); kora virtuoso and composer Foday Musa Suso (Gambia/United States); and award-winning composer and Chairman of the China Musicians' Association Professor Ye Xiaogang (China).

About The Glenn Gould Prize
An international symbol of creative excellence, The Glenn Gould Prize is awarded biennially to a living individual for a unique lifetime contribution that has enriched the human condition through the arts.  A tribute to Glenn Gould's artistry and his multifaceted contributions to culture, the prize promotes the vital connection between artistic excellence and the transformation of lives.  With its guiding principles of Celebration, Inspiration and Transformation, The Glenn Gould Prize stands as a symbol of artistic excellence and achievement, open to all nationalities and a wide range of creative disciplines.  Past laureates include Philip Glass (2015), Robert Lepage (2013), Leonard Cohen (2011), Dr. José Antonio Abreu (2008), founder of El Sistema, Pierre Boulez (2002), Yo-Yo Ma (1999), Oscar Peterson (1993) and Lord Yehudi Menuhin (1990). For more information visit www.glenngould.ca.

 

Contact Info: Karen Lorenowicz 416-245-2475 karen.lorenowicz@gmail.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: The Glenn Gould Foundation via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease20.4.2018 14:15Pressemelding

NEW YORK and CLEVELAND, April 20, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation (EMA/OD/013/18) for Abeona's gene therapy program ABO-202 for the treatment of subjects with neuronal ceroid lipofuscinosis, also known as Batten Disease, a fatal lysosomal storage disease that primarily affects the nervous system in children. ABO-202 is an adeno-associated virus developed to introduce a functional copy of the CLN1 gene into cells in order to restore the enzyme activity that is needed to break down certain lipopigment proteins that are deficient in patients with CLN1 disease. "This designation is an important step in our CLN1 program as it encourages us to proceed towards clinical development," st

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska20.4.2018 14:00Pressemelding

RENSSELAER, N.Y., April 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the technology, allowing Taconic rights to generate and sell rodent models generated via Easi-CRISPR. When compared to traditional CRISPR, Easi-CRISPR represents a significant advantage, allowing researchers to perform whole genetic insertions versus being limited to point mutations and constitutive knockouts. "Easi-CRISPR is the next progression of the revolutionary CRISPR/Cas technology. Combining the speed of CRISPR with larger genetic insertions allows complex projects typically requiring homologous recombinati

PayByPhone appoints Andreas Gruber as new President and CEO20.4.2018 00:19Pressemelding

VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- PayByPhone, the global leader in mobile parking payments, today announced that it will appoint Andreas Gruber as president and Chief Executive Officer effective June 1st, 2018. Francis Dupuis, the former President and CEO, will take over a position in Germany with parent company Volkswagen Financial Services AG. To provide additional impetus to the PayByPhone board, two new board positions have been created and as a result Maggie Clay (CFO) and Catherine Scott (Legal Counsel) will be appointed effective June 1st, 2018. During his time at PayByPhone, Francis led the business through significant growth and organizational change and leaves the company well positioned for continued success. "We would like to thank Francis for his strong leadership and look forward to building on his experience within Volkswagen Financial Services," Gerd Künne, Vice-President of mobility unit at Volkswagen Financial Services, said. Francis is e

Progress and Potential for Achieving Cleaner Air on a Global Basis20.4.2018 00:09Pressemelding

Adoption of New Generation Diesel Technology Delivers Rapid Clean Air Benefits New understanding of global air quality highlights the need for technologies like new-generation diesel engines, which are capable of accelerating emissions reductions WASHINGTON, April 19, 2018 (GLOBE NEWSWIRE) -- Recent reports highlighting air quality conditions in the United States (State of the Air) and globally (State of Global Air 2018) celebrate the progress made in developed and developing countries, but also emphasize significant disparities in progress toward reducing levels of key pollutants such as particulate matter and ozone. "Achieving continued clean air progress while also sustaining economic growth is possible. Cities and countries must move to proven cleaner engines and fuels," said Allen Schaeffer, executive director of the Diesel Technology Forum. "We can and should bring the tremendous benefits of new technology diesel engines to communities and countries large and small around the wor

SD-WAN for Office 365: Aryaka Helps eLearning company, City & Guilds Group, Improve Office 365 Application Response Time19.4.2018 18:54Pressemelding

Aryaka's Global SD-WAN reduces time for global users to open SharePoint files from 10 to 0.05 seconds; Outlook performance improves 9x worldwide LONDON, April 19, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, announced today its SD-WAN technology has enabled City & Guilds Group, a worldwide leader in workplace skills, eLearning, and executive coaching, to achieve faster Office 365 application response times leading to an increase in productivity and better collaboration between users in Europe and Asia-Pacific. Headquartered in London, the City & Guilds Group works with education providers, governments and major corporations to help shape and support skills development for employers in over 100 countries. Team members of the company are similarly scattered around the world and primarily collaborate using Microsoft Office 365 applications, but many remote users were struggling to access the group's instance of Office 365 hosted in Dublin. For example, it could ta

Canacol Energy Ltd. Announces Private Offering of Senior Notes19.4.2018 16:23Pressemelding

CALGARY, Alberta, April 19, 2018 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Corporation") (TSX:CNE) (OTCQX:CNNEF) (BVC:CNEC) is pleased to announce that it intends, subject to market and other conditions, to offer senior unsecured notes (the "Notes") in a private placement to qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), to non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act and pursuant to certain prospectus exemptions in Canada (the "Offering"). The Notes will be fully and unconditionally guaranteed by certain subsidiaries of Canacol. The interest rate, redemption prices and other terms of the Notes are to be determined upon pricing of the Offering. Canacol intends to use the net proceeds from the Offering: (i) to repay the outstanding amounts borrowed under its credit facility; (ii) to pay fees and expenses of the O

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom